Patent ID: 8226557

Claim:
A glucose monitoring system comprising: an in vivo glucose sensor that produces one or more signals indicative of a glucose concentration in a subject; and a portable analyte monitoring device comprising a housing, a port for receiving an electrochemical test strip that produces one or more signals indicative of a glucose concentration in a sample from a subject, a touch screen display unit coupled to the housing, a receiver unit coupled to the housing and in communication with the touch screen display unit, and a processor coupled to the housing and in communication with the receiver unit and the touch screen display unit wherein the receiver unit wirelessly receives the one or more signals generated by the in vivo glucose sensor, the processor analyzes the one or more signals produced by the electrochemical test strip and the one or more signals produced by the in vivo glucose sensor to: determine a drug administration protocol based on the glucose concentration, determine a rate of increase or decrease of the glucose concentration in the subject, and adjust the determined drug administration protocol based on the rate of increase or decrease in the glucose concentration to provide an adjusted drug administration protocol, and wherein the display is configured to display the adjusted drug administration protocol and provide an indicator of the rate of increase or decrease in the glucose concentration in the subject.